134 related articles for article (PubMed ID: 30364936)
1. 18β-glycyrrhetinic acid inhibited mitochondrial energy metabolism and gastric carcinogenesis through methylation-regulated TLR2 signaling pathway.
Cao D; Wu Y; Jia Z; Zhao D; Zhang Y; Zhou T; Wu M; Zhang H; Tsukamoto T; Oshima M; Jiang J; Cao X
Carcinogenesis; 2019 Apr; 40(2):234-245. PubMed ID: 30364936
[TBL] [Abstract][Full Text] [Related]
2. 18β-glycyrrhetinic acid regulates mitochondrial ribosomal protein L35-associated apoptosis signaling pathways to inhibit proliferation of gastric carcinoma cells.
Yuan L; Yang Y; Li X; Zhou X; Du YH; Liu WJ; Zhang L; Yu L; Ma TT; Li JX; Chen Y; Nan Y
World J Gastroenterol; 2022 Jun; 28(22):2437-2456. PubMed ID: 35979263
[TBL] [Abstract][Full Text] [Related]
3. 18β-glycyrrhetinic acid inhibits proliferation of gastric cancer cells through regulating the miR-345-5p/TGM2 signaling pathway.
Li X; Ma XL; Nan Y; Du YH; Yang Y; Lu DD; Zhang JF; Chen Y; Zhang L; Niu Y; Yuan L
World J Gastroenterol; 2023 Jun; 29(23):3622-3644. PubMed ID: 37398884
[TBL] [Abstract][Full Text] [Related]
4. 18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling.
Cao D; Jia Z; You L; Wu Y; Hou Z; Suo Y; Zhang H; Wen S; Tsukamoto T; Oshima M; Jiang J; Cao X
Oncotarget; 2016 Nov; 7(44):71960-71973. PubMed ID: 27713126
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of Atp4a concomitant with intragenic DNA demethylation for cancer inhibition in a gastric cancer model.
Cao D; Zhao D; Jia Z; Su T; Zhang Y; Wu Y; Wu M; Tsukamoto T; Oshima M; Jiang J; Cao X
Life Sci; 2020 Feb; 242():117214. PubMed ID: 31884095
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 2 regulates metabolic reprogramming in gastric cancer via superoxide dismutase 2.
Liu YD; Yu L; Ying L; Balic J; Gao H; Deng NT; West A; Yan F; Ji CB; Gough D; Tan P; Jenkins BJ; Li JK
Int J Cancer; 2019 Jun; 144(12):3056-3069. PubMed ID: 30536754
[TBL] [Abstract][Full Text] [Related]
7. Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer.
West AC; Tang K; Tye H; Yu L; Deng N; Najdovska M; Lin SJ; Balic JJ; Okochi-Takada E; McGuirk P; Keogh B; McCormack W; Bhathal PS; Reilly M; Oshima M; Ushijima T; Tan P; Jenkins BJ
Oncogene; 2017 Sep; 36(36):5134-5144. PubMed ID: 28481875
[TBL] [Abstract][Full Text] [Related]
8. 18β-glycyrrhetinic acid induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells.
Sharma G; Kar S; Palit S; Das PK
J Cell Physiol; 2012 May; 227(5):1923-31. PubMed ID: 21732363
[TBL] [Abstract][Full Text] [Related]
9. Exploring the molecular mechanism of glycyrrhetinic acid in the treatment of gastric cancer based on network pharmacology and experimental validation.
Li X; Du Y; Huang S; Yang Y; Lu D; Zhang J; Chen Y; Zhang L; Nan Y; Yuan L
Aging (Albany NY); 2023 May; 15(9):3839-3856. PubMed ID: 37171392
[TBL] [Abstract][Full Text] [Related]
10. NF-κB-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells.
Echizen K; Horiuchi K; Aoki Y; Yamada Y; Minamoto T; Oshima H; Oshima M
Oncogene; 2019 May; 38(22):4250-4263. PubMed ID: 30700829
[TBL] [Abstract][Full Text] [Related]
11. Antileishmanial effect of 18β-glycyrrhetinic acid is mediated by Toll-like receptor-dependent canonical and noncanonical p38 activation.
Gupta P; Das PK; Ukil A
Antimicrob Agents Chemother; 2015 May; 59(5):2531-9. PubMed ID: 25691644
[TBL] [Abstract][Full Text] [Related]
12. 25-HC decreases the sensitivity of human gastric cancer cells to 5-fluorouracil and promotes cells invasion via the TLR2/NF-κB signaling pathway.
Wang S; Yao Y; Rao C; Zheng G; Chen W
Int J Oncol; 2019 Mar; 54(3):966-980. PubMed ID: 30664194
[TBL] [Abstract][Full Text] [Related]
13. HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-κB Signaling and Promotes Tissue Damage-Associated Tumorigenesis.
Janeckova L; Pospichalova V; Fafilek B; Vojtechova M; Tureckova J; Dobes J; Dubuissez M; Leprince D; Baloghova N; Horazna M; Hlavata A; Stancikova J; Sloncova E; Galuskova K; Strnad H; Korinek V
Mol Cancer Res; 2015 Jul; 13(7):1139-48. PubMed ID: 25934696
[TBL] [Abstract][Full Text] [Related]
14. Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production.
Yuan X; Zhou Y; Wang W; Li J; Xie G; Zhao Y; Xu D; Shen L
Cell Death Dis; 2013 Sep; 4(9):e794. PubMed ID: 24030146
[TBL] [Abstract][Full Text] [Related]
15. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway.
Oshima H; Matsunaga A; Fujimura T; Tsukamoto T; Taketo MM; Oshima M
Gastroenterology; 2006 Oct; 131(4):1086-95. PubMed ID: 17030179
[TBL] [Abstract][Full Text] [Related]
16. Porphyromonas gingivalis Lipopolysaccharide Damages Mucosal Barrier to Promote Gastritis-Associated Carcinogenesis.
Oriuchi M; Lee S; Uno K; Sudo K; Kusano K; Asano N; Hamada S; Hatta W; Koike T; Imatani A; Masamune A
Dig Dis Sci; 2024 Jan; 69(1):95-111. PubMed ID: 37943385
[TBL] [Abstract][Full Text] [Related]
17. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
18. Myeloid Differentiation Factor 88 Signaling in Bone Marrow-Derived Cells Promotes Gastric Tumorigenesis by Generation of Inflammatory Microenvironment.
Maeda Y; Echizen K; Oshima H; Yu L; Sakulsak N; Hirose O; Yamada Y; Taniguchi T; Jenkins BJ; Saya H; Oshima M
Cancer Prev Res (Phila); 2016 Mar; 9(3):253-63. PubMed ID: 26888865
[TBL] [Abstract][Full Text] [Related]
19. 18β-glycyrrhetinic acid inhibits migration and invasion of human gastric cancer cells via the ROS/PKC-α/ERK pathway.
Cai H; Chen X; Zhang J; Wang J
J Nat Med; 2018 Jan; 72(1):252-259. PubMed ID: 29098529
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 1 Up-regulates MicroRNA 135b to Promote Inflammation-Associated Gastric Carcinogenesis in Mice.
Han TS; Voon DC; Oshima H; Nakayama M; Echizen K; Sakai E; Yong ZWE; Murakami K; Yu L; Minamoto T; Ock CY; Jenkins BJ; Kim SJ; Yang HK; Oshima M
Gastroenterology; 2019 Mar; 156(4):1140-1155.e4. PubMed ID: 30508510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
